Amedica Corporation to Host Third Quarter 2014 Earnings Conference Call

SALT LAKE CITY, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, announced today that it will release financial results for its third quarter 2014 on Thursday, November 6, 2014, at approximately 9:00 a.m. Eastern Time. A copy of the release will be available on the Amedica Corporation website at http://investors.amedica.com/releases.cfm. Following the release, the Company will host a conference call at 10:00 a.m. Eastern Time.

Amedica invites all interested parties to join the call by dialing (855) 455-6055 for domestic participants and (484) 756-4308 for international participants. All callers will be asked to reference Conference ID number 25349231. The call will also be broadcast live over the Internet and can be accessed on the Investors section of the Company's website at http://investors.amedica.com.

A telephone replay will be available for one week following the call by dialing (855) 859-2056 for domestic participants and (404) 537-3406 for international participants. When prompted, please enter the Conference ID number 25349231. For those who are not available to listen to the live webcast, the call will be archived on the investor relations section of the Amedica website under Events & Presentations.

About Amedica Corporation

Amedica is a company focused on the development and application of medical-grade silicon nitride ceramics. Amedica markets spinal fusion products and is developing a new generation of orthopaedic bearings for hip and knee arthroplasty. Amedica operates an ISO 13485 certified manufacturing facility and its spine products are FDA cleared, CE marked, and currently marketed in the U.S. and select markets in Europe and South America.

For more information on Amedica or its silicon nitride material platform, please visit www.amedica.com.

CONTACT: Mike Houston
         Director of Investor Relations
         801-839-3534
         mhouston@amedica.com

Released October 23, 2014